Cholangiocarcinoma--current classification and challenges towards personalised medicine.

about

Transforming big data into computational models for personalized medicine and health care.Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand.

P2860

Q31137610-A2DF0455-31CF-4397-A6CA-C919546F0BE0 Q50128422-F73E3CB7-1A09-476D-9074-7E74E57716B1

P2860

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

Item

http://www.wikidata.org/entity/Q51548085

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@en

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@nl

type

Item

label

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@en

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@nl

prefLabel

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@en

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@nl

P1476

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

@en

P2093

Bodil Andersson

http://www.w3.org/2001/XMLSchema#string

Johannes Byrling

http://www.w3.org/2001/XMLSchema#string

Roland Andersson

http://www.w3.org/2001/XMLSchema#string

P2860

Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors

Cancer review: Cholangiocarcinoma

Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update

Classification, diagnosis, and management of cholangiocarcinoma

Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).

Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States.

Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes.

Surgical strategy for bile duct cancer: Advances and current limitations.

Pathogenesis, diagnosis, and management of cholangiocarcinoma

The epidemiology of cholangiocarcinoma.

P304

641-643

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.3109/00365521.2015.1127409

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

György Marko-Varga

P577

2016-01-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26806118

http://www.w3.org/2001/XMLSchema#string

P921

cholangiocarcinoma

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

about

P2860

P2860

Cholangiocarcinoma--current classification and challenges towards personalised medicine.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921